Recognizing that this development bottleneck may ultimately limit the number of new medicines that can reach patients, Formation Bio, founded in 2016 as TrialSpark Inc., has built technology platforms, processes, and capabilities to accelerate all aspects of drug development and clinical trials. You will own the recurring workflows BD depends on, including project managing the end-to-end deal process across sourcing, diligence, negotiations, and contracting; the CRM, deal flow reporting, meeting cadence, the BD process, and the materials BD produces for leadership, the Board, and town halls.